Progress and challenges in translating the biology of atherosclerosis

Peter Libby1, Paul M Ridker, Göran K Hansson

  • 1Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, 77 Avenue Louis Pasteur, Boston, Massachusetts 02115, USA. plibby@rics.bwh.harvard.edu

Nature
|May 20, 2011
PubMed

Insights

Atherosclerosis research explores arterial wall disease, a major cause of death. Combining animal models and human studies is key to understanding its causes and developing new treatments.

Area of Science:

  • Cardiovascular Science
  • Immunology
  • Pathophysiology

Background:

  • Atherosclerosis is a chronic arterial disease and a leading global cause of mortality.
  • Significant research has generated hypotheses on lesion formation and complications like myocardial infarction and stroke.
  • Definitive evidence for the role of lipoprotein oxidation, inflammation, and immunity in human atherosclerosis remains elusive.

Purpose of the Study:

  • To investigate the complex pathophysiology of atherosclerosis.
  • To evaluate the contribution of inflammation and immunity to human atherosclerosis.
  • To explore the translational relevance of experimental atherosclerosis models.

Main Methods:

  • Review of existing research on atherosclerosis pathophysiology.
  • Analysis of hypotheses regarding lipoprotein oxidation, inflammation, and immunity.
  • Consideration of experimental animal models and their extrapolation to human disease.

Main Results:

  • Hypotheses regarding lipoprotein oxidation, inflammation, and immunity require further validation in human atherosclerosis.
  • Experimental animal models are valuable but require careful interpretation for human relevance.
  • A gap exists in definitive evidence linking specific inflammatory and immune processes to human atherosclerosis.

Conclusions:

  • Further research is needed to confirm the role of inflammation and immunity in human atherosclerosis.
  • Integrating findings from experimental models and clinical studies is crucial for advancing understanding.
  • Improved understanding may lead to novel clinical applications for managing atherosclerosis.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.8K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
1.1K
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
2.5K
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
961
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
747
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
621